Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

457

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Vortioxetine

Encapsulated vortioxetine immediate-release tablets

DRUG

Placebo

Vortioxetine placebo-matching capsules

Trial Locations (40)

Unknown

Birmingham

Anaheim

Cerritos

Costa Mesa

Orange

Redlands

Cromwell

Norwich

Hockessin

Fort Myers

Jacksonville

Lady Lake

Miami

Atlanta

Chicago

Libertyville

Valparaiso

Overland Park

Prairie Village

Boston

Braintree

Pittsfield

St Louis

Cherry Hill

Fresh Meadows

New York

Olean

Cincinnati

Columbus

Middleburg Heights

Oklahoma City

Emmaus

Philadelphia

Reading

North Charleston

Nashville

Houston

San Antonio

Midlothian

Waukesha

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Takeda

INDUSTRY